In 2017 David cycled all the way from London to Amsterdam to raise money for Secondary1st. He had recently lost his wife Joanne to secondary breast cancer and Secondary1st was a charity which had been very close to her heart. To continue his support David joined our team of Trustees to use his experience and…
JH Mechanical Services are most generously continuing to raise funds for Secondary1st as their chosen charity. From the beginning of April to the end of October each member of their team will take on the “Walk 500 Challenge” and walk or run 500 miles to raise money for research into secondary breast cancer. Added together…
The sun was shining in a clear blue sky when Tim jumped… out of a plane 3 miles up. It had taken about 12 minutes for the Cessna Super Cargomaster to climb to the correct altitude. Then Tim and his tandem skydive instructor Alex were out in freefall, reaching a speed of 125 mph for…
Tracey started 2020 with plans to take part in a number of events to raise more money for Secondary1st. She completed the 50km Winter Walk in London and was training for the 50km Easter Walk around Windsor, but it was cancelled because of the pandemic so she completed a virtual 50km challenge and booked in…
Tim is planning to do something he’s never done before to raise funds for Secondary1st and increase awareness of secondary breast cancer; he’s going to skydive 10,000 feet from a plane. It will take about 15 minutes for the plane to reach its planned altitude. When he leaves the plane Tim will be in freefall…
The NHS in England is introducing a more efficient way of administering a treatment for HER2 positive early and metastatic breast cancer. The new treatment is called Phesgo and is a combination of Perjeta (pertuzumab) and Herceptin (trastuzumab), two monoclonal antibodies. Phesgo uses new ENHANZE technology to deliver a sub-cutaneous fixed dose injection which can…
Nice, the National Institute for Health and Care Excellence, has recommended the use of ribociclib, also known as Kisqali for routine use by the NHS in England and Wales, after it was originally made available through the Cancer Drugs Fund. Their draft guidance recommends ribociclib plus fulvestrant as an option for treating hormone receptor-positive, human…
Dr Coffelt and his team at the Beatson Institute of the University of Glasgow are investigating the role of a type of immune cell called gamma delta T cells in helping breast cancer spread through the body and received grants from Secondary1st in 2019 and 2020.
Dr Pors and his team at the Institute of Cancer Therapeutics at the University of Bradford received a grant from Secondary1st in October 2019, but the lab was closed for a large part of 2020. To mark World Cancer Day on February 4th he tweeted “We are developing tumour-targeted prodrugs & training the next generation…
NHS England has announced that it is rolling out a new blood test which aims to detect whether some cancer patients are genetically prone to experience more serious effects from some chemotherapy treatments. These treatments can then be tailored more closely to the patients’ genetic makeup and so avoid the most serious side effects. Drugs…
Sharon was 45 when she was diagnosed with stage 3 breast cancer. She was immediately booked in for a single mastectomy, followed by a course of chemo sessions and radiotherapy. On the day of her surgery when she came round from the general anaesthetic, the first thing she asked for was her lip gloss and…
Thanks to our wonderful Donors and Fundraisers Secondary1st has been able to make a second grant of £65,000 to the research project led by Dr Seth Coffelt at the Beatson Institute at the University of Glasgow. Dr Coffelt and his team are investigating the role of a type of immune cell called gamma delta T…